Literature DB >> 30596278

Prebiotic Chondroitin Sulfate Disaccharide Isolated from Chicken Keel Bone Exhibiting Anticancer Potential Against Human Colon Cancer Cells.

Aruna Rani1, Rwivoo Baruah1, Arun Goyal1.   

Abstract

Chondroitin sulfate (CS)-Keel disaccharide (CSD) was produced by chondroitin AC lyase (PsPL8A) degradation of food grade CS-Keel polysaccharide isolated from chicken keel cartilage. PsPL8A showed specific activity, 340 ± 5.2 U mg-1 with CS-Keel polysaccharide. TLC showed CSD as the major product. CSD was purified by gel filtration and MS/MS, confirms it as C4S disaccharide. Structural characterization by FTIR and NMR showed presence of N-acetylgalactosamine and glucuronic acid. CSD displayed resistance to gastric juice with 23.7% hydrolysis at pH 1.0. CSD showed prebiotic score of 0.57 for L. acidophilus and 0.58 for B. infantis and produce SCFA products. MTT and morphological analysis confirmed, CSD (0.5 mg mL-1) does not decrease viability of mouse fibroblast (L929), but showed anti-proliferative potential against human colon cancer (HT-29) cell lines (80% inhibition). CSD treated HT-29 cells exhibit nuclear fragmentation and apoptosis. Prebiotic and anticancer potential of CSD can be utilized for functional food preparation and prevention of gastrointestinal disorders.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30596278     DOI: 10.1080/01635581.2018.1521446

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  5 in total

Review 1.  Drug Screening Implicates Chondroitin Sulfate as a Potential Longevity Pill.

Authors:  Collin Y Ewald
Journal:  Front Aging       Date:  2021-09-08

Review 2.  Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics.

Authors:  Zhentian Wei; Feng Li; Guofu Pi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

3.  Enzymatic Production of Chondroitin Oligosaccharides and Its Sulfate Derivatives.

Authors:  Weijiao Zhang; Ruirui Xu; Xuerong Jin; Yang Wang; Litao Hu; Tianmeng Zhang; Guocheng Du; Zhen Kang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-13

Review 4.  Advances in Nanofabrication Technology for Nutraceuticals: New Insights and Future Trends.

Authors:  Rachitha Puttasiddaiah; Rohitha Lakshminarayana; Nandini Lalithadripura Somashekar; Vijai Kumar Gupta; Baskaran Stephen Inbaraj; Zeba Usmani; Vinay Basavegowda Raghavendra; Kandi Sridhar; Minaxi Sharma
Journal:  Bioengineering (Basel)       Date:  2022-09-16

Review 5.  An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics.

Authors:  Alessandra Durazzo; Amirhossein Nazhand; Massimo Lucarini; Atanas G Atanasov; Eliana B Souto; Ettore Novellino; Raffaele Capasso; Antonello Santini
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.